Medicines Act Corrigendum




6 NOVEMBER 2008 NEW ZEALAND GAZETTE, No. 169 4433

Medicines Act 1981

Corrigendum—Consent to the Distribution of a Medicine

In the notice published in the New Zealand Gazette, 23 October 2008, No. 162, page 4246, the following product entries are to be deleted from Full Consent, section 20 and to be placed under Provisional Consent, section 23 with the heading as follows:

Provisional Consent to the Distribution of a Medicine

Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the medicine set out in the Schedule hereto:

Schedule

Product: Levothyroxine
Active Ingredient: Levothyroxine sodium, anhydrous 50µg
Dosage Form: Tablet
New Zealand Sponsor: Boucher & Muir New Zealand Limited t/a Goldshield Healthcare (New Zealand)
Manufacturer: Custom Pharmaceuticals Limited (UK), Brighton, East Sussex, United Kingdom

Product: Levothyroxine
Active Ingredient: Levothyroxine sodium, anhydrous 100µg
Dosage Form: Tablet
New Zealand Sponsor: Boucher & Muir New Zealand Limited t/a Goldshield Healthcare (New Zealand)
Manufacturer: Custom Pharmaceuticals Limited (UK), Brighton, East Sussex, United Kingdom

Product: Synthroid
Active Ingredient: Levothyroxine sodium, anhydrous 100µg
Dosage Form: Tablet
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturer: Abbott Laboratories Inc, Puerto Rico, United States of America

Product: Synthroid
Active Ingredient: Levothyroxine sodium, anhydrous 112µg
Dosage Form: Tablet
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturer: Abbott Laboratories Inc, Puerto Rico, United States of America

Product: Synthroid
Active Ingredient: Levothyroxine sodium, anhydrous 125µg
Dosage Form: Tablet
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturer: Abbott Laboratories Inc, Puerto Rico, United States of America

Product: Synthroid
Active Ingredient: Levothyroxine sodium, anhydrous 137µg
Dosage Form: Tablet
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturer: Abbott Laboratories Inc, Puerto Rico, United States of America

Product: Synthroid
Active Ingredient: Levothyroxine sodium, anhydrous 150µg
Dosage Form: Tablet
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturer: Abbott Laboratories Inc, Puerto Rico, United States of America

Product: Synthroid
Active Ingredient: Levothyroxine sodium, anhydrous 175µg
Dosage Form: Tablet
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturer: Abbott Laboratories Inc, Puerto Rico, United States of America

Product: Synthroid
Active Ingredient: Levothyroxine sodium, anhydrous 200µg
Dosage Form: Tablet
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturer: Abbott Laboratories Inc, Puerto Rico, United States of America

Product: Synthroid
Active Ingredient: Levothyroxine sodium, anhydrous 25µg
Dosage Form: Tablet
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturer: Abbott Laboratories Inc, Puerto Rico, United States of America



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2008, No 169





✨ LLM interpretation of page content

🏥 Corrigendum to Medicines Act 1981 Consent

🏥 Health & Social Welfare
Medicines Act, Corrigendum, Medicine Distribution, Provisional Consent